Who invested in Harmony Biosciences

One round we have observed, with the 5 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Pharma

Funding summaryUpdated 26 Oct 2026

$248Mraised across 1 round since 2024, from 1 source

Latest round: Secondary, $248MOct 2024
Investors: 5

See who backed them

The rounds

Oct 2024
Secondary$248M
Source recorded

Founders and team

From Harmony Biosciences's own website: 1 founder, 9 on the team.

Jeffrey S. AroninHarmony Founder and Non-Executive Chairman

Cate McCanlessSenior Vice President and Chief Corporate Affairs Officer
Harmony BiosciencesPresident and Chief Executive Officer
Orbital TherapeuticsChief Executive Officer
Ron PhilipPresident and Chief Executive Officer
Audrey MurphyChief Human Resources Officer
Peter AnastasiouChief Operating Officer
Tricia GloverChief Compliance Officer
Troy IgnelziChief Financial Officer
Juan SabaterPartner

Everyone who backed them

OrbiMedPrivate equity1round

FidelityVC firm1round

Valor Equity PartnersVC firm1round

Novo HoldingsVC firm1round

Vivo CapitalPrivate equity1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Harmony Biosciences as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.